| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.064 | 0.2 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |